International differences in cardiovascular clinical trials. Introduction

Eptifibatide in percutaneous coronary intervention. A review.

Minerva cardioangiologica·2002

Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).

The American journal of cardiology·2001

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.

Journal of the American College of Cardiology·2001

Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.

Circulation·2001

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.

JAMA·2001

Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention.

American heart journal·2000

Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange (SCD-CARRE) trial.

American heart journal·2026

Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study.

American heart journal·2026

Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022).

American heart journal·2026

Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysis.

American heart journal·2026

Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: win-ratio reanalysis of the TRANSFORM-HF trial.

American heart journal·2026

Efficacy and safety of human albumin combined with furosemide in acute decompensated heart failure with hepatic dysfunction.

American heart journal·2026

Comparison of index-level reoperation-free survival and complication rates between endoscopic and conventional transforaminal lumbar interbody fusion: a retrospective comparative study in Korea.

Asian spine journal·2026

Claudin 18.2 Targeting: A Pan-Cancer Perspective.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Taking International Law Seriously? Interpretation of the 1998 Belfast/Good Friday Agreement in the Context of Article 2(1) of the Windsor Framework.

Oxford journal of legal studies·2026

Time-motion Analysis of Female Para Judo Athletes With Visual Impairments: Influence of the New Sport Classes and Weight Categories.

American journal of physical medicine & rehabilitation·2026

Classification of iliac vessels and selection of surgical approach and window in oblique lumbar interbody fusion at L5-S1 based on magnetic resonance imaging.

Frontiers in surgery·2026

The impact of fingermark analysis Guidelines and fingerprint quality assessment software on the evaluation of fingermark value within the Indonesian National Police.

Science & justice : journal of the Forensic Science Society·2026

Related Experiment Videos

International differences in cardiovascular clinical trials. Introduction

Related Concept Videos

Eptifibatide in percutaneous coronary intervention. A review.

Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.

Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.

Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention.

Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange (SCD-CARRE) trial.

Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study.

Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022).

Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysis.

Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: win-ratio reanalysis of the TRANSFORM-HF trial.

Efficacy and safety of human albumin combined with furosemide in acute decompensated heart failure with hepatic dysfunction.

Comparison of index-level reoperation-free survival and complication rates between endoscopic and conventional transforaminal lumbar interbody fusion: a retrospective comparative study in Korea.

Claudin 18.2 Targeting: A Pan-Cancer Perspective.

Taking International Law Seriously? Interpretation of the 1998 Belfast/Good Friday Agreement in the Context of Article 2(1) of the Windsor Framework.

Time-motion Analysis of Female Para Judo Athletes With Visual Impairments: Influence of the New Sport Classes and Weight Categories.

Classification of iliac vessels and selection of surgical approach and window in oblique lumbar interbody fusion at L5-S1 based on magnetic resonance imaging.

The impact of fingermark analysis Guidelines and fingerprint quality assessment software on the evaluation of fingermark value within the Indonesian National Police.

Related Experiment Videos

International differences in cardiovascular clinical trials. Introduction

Related Concept Videos

Related Articles